Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Saved in:
| Title: | Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial. |
|---|---|
| Authors: | Clark AS; University of Pennsylvania, Philadelphia, PA, USA. Amy.Clark@pennmedicine.upenn.edu., Yau C; University of California San Francisco, San Francisco, CA, USA., Wolf DM; University of California San Francisco, San Francisco, CA, USA., Petricoin EF; George Mason University, Fairfax, VA, USA., van 't Veer LJ; University of California San Francisco, San Francisco, CA, USA., Yee D; University of Minnesota, Minneapolis, MN, USA., Moulder SL; MD Anderson Cancer Center, Houston, TX, USA., Wallace AM; University of California San Diego, San Diego, CA, USA., Chien AJ; University of California San Francisco, San Francisco, CA, USA., Isaacs C; Georgetown University, Washington, DC, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Albain KS; Loyola University, Chicago, IL, USA., Kemmer K; Oregon Health & Science University, Portland, OR, USA., Haley BB; University of Texas Southwestern, Dallas, TX, USA., Han HS; Moffitt Cancer Center, Tampa, FL, USA., Forero-Torres A; University of Alabama Birmingham, Birmingham, AL, USA., Elias A; University of Colorado Denver, Aurora, CO, USA., Lang JE; University of Southern California, Los Angeles, CA, USA., Ellis ED; Swedish Cancer Institute, Seattle, WA, USA., Yung R; University of Washington, Seattle, WA, USA., Tripathy D; MD Anderson Cancer Center, Houston, TX, USA., Nanda R; University of Chicago, Chicago, IL, USA., Wulfkuhle JD; MD Anderson Cancer Center, Houston, TX, USA., Brown-Swigart L; University of California San Francisco, San Francisco, CA, USA., Gallagher RI; MD Anderson Cancer Center, Houston, TX, USA., Helsten T; University of California San Diego, San Diego, CA, USA., Roesch E; University of California San Diego, San Diego, CA, USA., Ewing CA; University of California San Francisco, San Francisco, CA, USA., Alvarado M; University of California San Francisco, San Francisco, CA, USA., Crane EP; Georgetown University, Washington, DC, USA., Buxton M; Berry Consultants, LLC, Houston, TX, USA., Clennell JL; Berry Consultants, LLC, Houston, TX, USA., Paoloni M; Berry Consultants, LLC, Houston, TX, USA., Asare SM; University of California San Francisco, San Francisco, CA, USA., Wilson A; University of California San Francisco, San Francisco, CA, USA., Hirst GL; University of California San Francisco, San Francisco, CA, USA., Singhrao R; University of California San Francisco, San Francisco, CA, USA., Steeg K; University of California San Francisco, San Francisco, CA, USA., Asare A; University of California San Francisco, San Francisco, CA, USA., Matthews JB; University of California San Francisco, San Francisco, CA, USA., Berry S; Berry Consultants, LLC, Houston, TX, USA., Sanil A; Berry Consultants, LLC, Houston, TX, USA., Melisko M; University of California San Francisco, San Francisco, CA, USA., Perlmutter J; Gemini Group, Ann Arbor, MI, USA., Rugo HS; University of California San Francisco, San Francisco, CA, USA., Schwab RB; University of California San Diego, San Diego, CA, USA., Symmans WF; MD Anderson Cancer Center, Houston, TX, USA., Hylton NM; University of California San Francisco, San Francisco, CA, USA., Berry DA; Berry Consultants, LLC, Houston, TX, USA., Esserman LJ; University of California San Francisco, San Francisco, CA, USA., DeMichele AM; University of Pennsylvania, Philadelphia, PA, USA. |
| Source: | Nature communications [Nat Commun] 2021 Nov 05; Vol. 12 (1), pp. 6428. Date of Electronic Publication: 2021 Nov 05. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34741023 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2<superscript>+</superscript> breast cancer in the adaptively randomized I-SPY2 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Clark+AS%22">Clark AS</searchLink>; University of Pennsylvania, Philadelphia, PA, USA. Amy.Clark@pennmedicine.upenn.edu.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wolf+DM%22">Wolf DM</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Petricoin+EF%22">Petricoin EF</searchLink>; George Mason University, Fairfax, VA, USA.<br /><searchLink fieldCode="AU" term="%22van+'t+Veer+LJ%22">van 't Veer LJ</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yee+D%22">Yee D</searchLink>; University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Moulder+SL%22">Moulder SL</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wallace+AM%22">Wallace AM</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chien+AJ%22">Chien AJ</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Georgetown University, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Boughey+JC%22">Boughey JC</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Albain+KS%22">Albain KS</searchLink>; Loyola University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Kemmer+K%22">Kemmer K</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Haley+BB%22">Haley BB</searchLink>; University of Texas Southwestern, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Han+HS%22">Han HS</searchLink>; Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; University of Alabama Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Elias+A%22">Elias A</searchLink>; University of Colorado Denver, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Lang+JE%22">Lang JE</searchLink>; University of Southern California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ellis+ED%22">Ellis ED</searchLink>; Swedish Cancer Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Yung+R%22">Yung R</searchLink>; University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Tripathy+D%22">Tripathy D</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Nanda+R%22">Nanda R</searchLink>; University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Wulfkuhle+JD%22">Wulfkuhle JD</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Brown-Swigart+L%22">Brown-Swigart L</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gallagher+RI%22">Gallagher RI</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Helsten+T%22">Helsten T</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Roesch+E%22">Roesch E</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ewing+CA%22">Ewing CA</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Alvarado+M%22">Alvarado M</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Crane+EP%22">Crane EP</searchLink>; Georgetown University, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Buxton+M%22">Buxton M</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Clennell+JL%22">Clennell JL</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Paoloni+M%22">Paoloni M</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Asare+SM%22">Asare SM</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+A%22">Wilson A</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hirst+GL%22">Hirst GL</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Singhrao+R%22">Singhrao R</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Steeg+K%22">Steeg K</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Asare+A%22">Asare A</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+JB%22">Matthews JB</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Berry+S%22">Berry S</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sanil+A%22">Sanil A</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Melisko+M%22">Melisko M</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Perlmutter+J%22">Perlmutter J</searchLink>; Gemini Group, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schwab+RB%22">Schwab RB</searchLink>; University of California San Diego, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hylton+NM%22">Hylton NM</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Berry+DA%22">Berry DA</searchLink>; Berry Consultants, LLC, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22DeMichele+AM%22">DeMichele AM</searchLink>; University of Pennsylvania, Philadelphia, PA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 Nov 05; Vol. 12 (1), pp. 6428. <i>Date of Electronic Publication: </i>2021 Nov 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34741023 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-021-26019-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6428 Titles: – TitleFull: Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Clark AS – PersonEntity: Name: NameFull: Yau C – PersonEntity: Name: NameFull: Wolf DM – PersonEntity: Name: NameFull: Petricoin EF – PersonEntity: Name: NameFull: van 't Veer LJ – PersonEntity: Name: NameFull: Yee D – PersonEntity: Name: NameFull: Moulder SL – PersonEntity: Name: NameFull: Wallace AM – PersonEntity: Name: NameFull: Chien AJ – PersonEntity: Name: NameFull: Isaacs C – PersonEntity: Name: NameFull: Boughey JC – PersonEntity: Name: NameFull: Albain KS – PersonEntity: Name: NameFull: Kemmer K – PersonEntity: Name: NameFull: Haley BB – PersonEntity: Name: NameFull: Han HS – PersonEntity: Name: NameFull: Forero-Torres A – PersonEntity: Name: NameFull: Elias A – PersonEntity: Name: NameFull: Lang JE – PersonEntity: Name: NameFull: Ellis ED – PersonEntity: Name: NameFull: Yung R – PersonEntity: Name: NameFull: Tripathy D – PersonEntity: Name: NameFull: Nanda R – PersonEntity: Name: NameFull: Wulfkuhle JD – PersonEntity: Name: NameFull: Brown-Swigart L – PersonEntity: Name: NameFull: Gallagher RI – PersonEntity: Name: NameFull: Helsten T – PersonEntity: Name: NameFull: Roesch E – PersonEntity: Name: NameFull: Ewing CA – PersonEntity: Name: NameFull: Alvarado M – PersonEntity: Name: NameFull: Crane EP – PersonEntity: Name: NameFull: Buxton M – PersonEntity: Name: NameFull: Clennell JL – PersonEntity: Name: NameFull: Paoloni M – PersonEntity: Name: NameFull: Asare SM – PersonEntity: Name: NameFull: Wilson A – PersonEntity: Name: NameFull: Hirst GL – PersonEntity: Name: NameFull: Singhrao R – PersonEntity: Name: NameFull: Steeg K – PersonEntity: Name: NameFull: Asare A – PersonEntity: Name: NameFull: Matthews JB – PersonEntity: Name: NameFull: Berry S – PersonEntity: Name: NameFull: Sanil A – PersonEntity: Name: NameFull: Melisko M – PersonEntity: Name: NameFull: Perlmutter J – PersonEntity: Name: NameFull: Rugo HS – PersonEntity: Name: NameFull: Schwab RB – PersonEntity: Name: NameFull: Symmans WF – PersonEntity: Name: NameFull: Hylton NM – PersonEntity: Name: NameFull: Berry DA – PersonEntity: Name: NameFull: Esserman LJ – PersonEntity: Name: NameFull: DeMichele AM IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 11 Text: 2021 Nov 05 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |